The aims of this study are to
1. Identify the early and midterm outcomes in terms of mortality and reoperation of the arterial switch operation (ASO). 2. Identifying the influence of coronary artery anomalies on the in-hospital and post-discharge prognosis after ASO. 3. Evaluate the predictors for neoaortic valve regurgitation after ASO. 4. Explore the risk factors for neopulmonary artery stenosis after ASO.
None
Patients with various forms of TGA undergoing Réparation à l'Etage Ventriculaire procedure
Patients with various forms of TGA undergoing Rastelli procedure
Patients with various forms of TGA undergoing Nikaidoh procedure
Patients with various forms of TGA undergoing Fontan operation
All participants diagnosed with TGA or TBA underwent ASO in the hospital with an eligible cardiovascular surgery center.
Cohort
Prospective
Not listed
All cause mortality
Number of participants with all cause mortality after ASO
Cardiac caused mortality
Number of participants with cardiac caused mortality after ASO
All cause reoperation
Number of participants with all cause reoperation after ASO
Right-ventricular outflow tract obstruction and pulmonary branch stenosis
Degree of more than moderate right-ventricular outflow tract obstruction in millimetre of mercury, degree of pulmonary branch stenosis in millimetre of mercury
Neoaortic valve regurgitation
Vena contracta width of neoaortic valve regurgitation in milimetre, ratio of Jet width/LVOT width in percentage
Click on the lead sponsor to view all of their trials.
Xie Mingxing
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Sponsor institution
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborator
Shanghai Zhongshan Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator
Wuhan Asia Heart Hospital
Collaborator
Guangdong Provincial People's Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
